Literature DB >> 32302508

hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.

Long Han1, Jian Cheng2, Afeng Li2.   

Abstract

Background: Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity. It was determined that circular RNAs were related to the development and progression of various cancers, including OSCC. The purpose of our study was to define the role and potential mechanism of hsa_circ_0072387 in OSCC progression. Materials and
Methods: Thirty-five patients with OSCC were involved in this study. Real-time quantitative polymerase chain reaction was used to evaluate the expression levels of hsa_circ_0072387 and microRNA (miR)-503-5p. Cell proliferation, migration, and invasion abilities were assessed by Cell Counting Kit-8 (CCK-8) and Transwell assays, respectively. The abundance of cell proliferation marker Ki-67, epithelial-mesenchymal transition (EMT) markers E-cadherin, N-cadherin, and vimentin was analyzed by Western blot assay. Glycolysis was evaluated using commercial kits. The interaction between hsa_circ_0072387 and miR-503-5p was confirmed by bioinformatics analysis, RNA immunoprecipitation (RIP) assay, and dual-luciferase reporter assay.
Results: hsa_circ_0072387 expression was significantly downregulated, and miR-503-5p was upregulated in OSCC cells and tissues. Gain of hsa_circ_0072387 or knockdown of miR-503-5p suppressed the cell proliferation, migration and invasion, EMT, and glycolysis in OSCC SCC-4 and HSC-3 cells. hsa_circ_0072387 targeted miR-503-5p and inversely regulated miR-503-5p expression. Moreover, upregulation of miR-503-5p could partially revert the tumor-suppressive effects of hsa_circ_0072387 on OSCC cells.
Conclusion: hsa_circ_0072387 inhibited OSCC progression by downregulating miR-503-5p, explicating that hsa_circ_0072387 could function as a novel potential therapeutic target for OSCC.

Entities:  

Keywords:  glycolysis; hsa_circ_0072387; metastasis; miR-503-5p; oral squamous cell carcinoma; proliferation

Year:  2020        PMID: 32302508     DOI: 10.1089/cbr.2019.3371

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  5 in total

1.  LncRNA PART1 Exerts Tumor-Suppressive Functions in Tongue Squamous Cell Carcinoma via miR-503-5p.

Authors:  Xiqun Zhao; Yanqing Hong; Qingyuan Cheng; Lixin Guo
Journal:  Onco Targets Ther       Date:  2020-10-07       Impact factor: 4.147

2.  Circ_0003266 sponges miR-503-5p to suppress colorectal cancer progression via regulating PDCD4 expression.

Authors:  Caihong Wen; Xiaoqing Feng; Honggang Yuan; Yong Gong; Guangsheng Wang
Journal:  BMC Cancer       Date:  2021-03-16       Impact factor: 4.430

3.  NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.

Authors:  Guangping Zhang; Xin Zhao; Weixian Liu
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.742

4.  Screening and Biological Function Analysis of miRNA and mRNA Related to Lung Adenocarcinoma Based on Bioinformatics Technology.

Authors:  Kaining Jia; Xiaocang Ren; Yuee Liu; Jiawei Wang
Journal:  J Oncol       Date:  2022-08-31       Impact factor: 4.501

5.  Exosomal cargoes in OSCC: current findings and potential functions.

Authors:  Chengzhi Zhao; Geru Zhang; Jialing Liu; Chenghao Zhang; Yang Yao; Wen Liao
Journal:  PeerJ       Date:  2020-11-03       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.